SCHEMBL5145850

SCHEMBL5145850

CC1(C)NC(=O)N(CCNc2ncc(-c3cccc(O)c3)c(-c3cc4ccccc4s3)n2)C1=O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B1 P14061 1/20 0.38
HSD17B2 P37059 1/20 0.38
RAF1 P04049 9/20 0.37
BRAF P15056 9/20 0.37
ADORA1 P30542 4/20 0.36
FLT3 P36888 2/20 0.34
ERN1 O75460 1/20 0.34
ABL1 P00519 1/20 0.34
FGFR1 P11362 1/20 0.34
MAPK8 P45983 1/20 0.34
MAPK11 Q15759 1/20 0.34
MAPK14 Q16539 1/20 0.34
NTRK2 Q16620 1/20 0.34
HIPK1 Q86Z02 1/20 0.34
MAP3K20 Q9NYL2 1/20 0.34
TNIK Q9UKE5 1/20 0.34
ALDH1A1 P00352 2/20 0.34
EGFR P00533 2/20 0.33
ESR1 P03372 1/20 0.33
ESR2 Q92731 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5149101 0.92 RAF1 (0.37) RAF1BRAFADORA1FLT3ERN1
SCHEMBL5179687 0.90 ADORA1 (0.37) ADORA1ALDH1A1
SCHEMBL5147347 0.88 ADORA1 (0.38) RAF1BRAFADORA1FLT3ERN1
SCHEMBL5147476 0.88 HSD17B1 (0.39) HSD17B1HSD17B2RAF1BRAFADORA1
SCHEMBL5149006 0.87 ADORA1 (0.39) RAF1BRAFADORA1FLT3ERN1
SCHEMBL2978018 0.87 HSD17B1 (0.39) HSD17B1HSD17B2RAF1BRAFADORA1
SCHEMBL5147380 0.83 ALDH1A1 (0.40) ALDH1A1LMNATSHRMAPK1HTT
SCHEMBL5145833 0.82 ALDH1A1 (0.43) ADORA1ABL1ALDH1A1LMNATSHR
SCHEMBL5147280 0.81 BRAF (0.37) RAF1BRAFADORA1FLT3ABL1
SCHEMBL5145972 0.81 RAF1 (0.39) RAF1BRAFFLT3ERN1ABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1831207-A1 AMINOPYRIMIDINE COMPOUNDS AND METHODS OF USE Amgen Inc. (US) 2007-09-12 EP disclosed
WO-2006066172-A1 AMINOPYRIMIDINE COMPOUNDS AND METHODS OF USE AMGEN, INC. (US) 2006-06-22 WO disclosed